Study of Periodontal Treatment During Pregnancy to Reduce Risks of Preterm Birth, Low Birthweight, and Pregnancy Complications
Led by University Hospital Bispebjerg and Frederiksberg · Updated on 2025-03-30
600
Participants Needed
3
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to study pregnant women who develop periodontitis, a common chronic gum disease that causes inflammation and can harm both oral and general health. The study investigates whether treating periodontitis during pregnancy can improve outcomes such as fetal growth, reduce the risk of preterm birth, low birth weight, and markers related to preeclampsia and gestational diabetes. The study also explores how periodontitis-related inflammation might affect the future health and metabolism of the child.
The study compares two groups of pregnant women diagnosed with periodontitis one group receiving periodontal treatment during pregnancy and another receiving the same treatment postpartum. Treatment involves up to five periodontal therapy sessions over about 20 weeks. Recruitment and treatment periods last 18 months for each group. The study collects detailed information on participants oral health, lifestyle, and socioeconomic factors through questionnaires at various stages during and after pregnancy.
Participants will attend scheduled visits for dental exams and periodontal treatment, along with completing online questionnaires about diet, smoking, physical activity, and oral health habits at baseline, week 35 of gestation, and at two and six months postpartum. Researchers will monitor pregnancy outcomes including preterm birth, low birth weight, and risk markers for preeclampsia and gestational diabetes over 18 months. The study also includes follow-up questionnaires on infant growth and family oral health after birth.
CONDITIONS
Brief Title
Oral Health and Adverse Pregnancy Complications
Research Team
K
Karoline Winckler, Phd
K
Kathrine Bukkehave, Dentist
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Pregnant women who are planned to give birth at either Holbaek or Nykoebing Falster hospital
Pregnant women diagnosed with periodontitis (stage I-III) by the study dentist
You will not qualify if you...
Pregnant women without periodontitis
Pregnant women with less than 20 healthy teeth
Pregnant women with periodontitis currently receiving treatment
Pregnant women with periodontitis stage IV
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit with a study dentist
Treatment
Duration - Approximately 20 weeks
Participants diagnosed with periodontitis receive up to 5 periodontal treatments either during pregnancy or after giving birth to investigate effects on pregnancy outcomes.
Up to 5 treatment visits
Monitoring
Duration - From baseline (week 11-13 of gestation) through 6 months postpartum
Participants complete online questionnaires about diet, smoking, physical activity, oral health, and baby growth at baseline, late pregnancy, and postpartum to monitor health and outcomes.
4 online questionnaire timepoints
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing 1 Hour Versus 2 Hours Post-Meal Blood Sugar Monitoring in Pregnant Women with Gestational Diabetes on Treatment
Multicenter Study on Maternal and Infant Microbiome and New Screening Targets for Preeclampsia in Pregnant Women in China
Randomized Trial Comparing Immediate Postpartum Diabetes Screening to Standard 4-12 Week Screening
and Follow-Up Study on Patient Perspectives to Improve Cardiovascular Health After Gestational Diabetes
Study of Safety and Effects of Single Dose CBP-4888 Injection in Hospitalized Pregnant Women with Preterm Preeclampsia
and Follow-Up of Their Children up to 24 Months
Observational Study Evaluating Blood Biomarkers and Retinal Imaging to Predict Pregnancy Complications in First-Time Pregnant Women
Study of the Erchonia FX-405 Laser Used Alongside Standard Gum Disease Treatment to Improve Periodontitis in Adults Aged 22 to 75
Study to Find the Best Dose and Method of Giving Anakinra to Very Premature Infants Born Between 24 and 28 Weeks
Comparing Inflammatory Biomarker Changes in Dried Blood Spot and Venous Blood Samples Following Controlled Stressors
Study of Maternal Melatonin Supplementation to Protect Brain Development in Severe Early Preterm Fetal Growth Restriction
Study of Amoxicillin and Metronidazole or Azithromycin to Improve Periodontal Treatment Outcomes
Pharmacokinetics and Dosing in Adults with Severe Gum Disease
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The prevention of adverse pregnancy outcomes by periodontal treatment during pregnancy (PROBE) intervention study-A controlled intervention study: Protocol paper.
Karoline Winckler, Kathrine Hansen Bukkehave, Lise Tarnow...